Skip to main content
TEVA logo
TEVA
(NYSE)
Teva Pharmaceutical Industries Limited
$36.77-- (--)
Loading... - Market loading

Teva Pharmaceutical Industries (TEVA) Stock Price & Financial Analysis

Teva Pharmaceutical Industries Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$36.09 - $36.81
52-Week High$37.35
52-Week Low$16.26
Open$36.26
Volume2.33M
Average Volume (3M)5.54M
Market Cap42.80B
Shares Outstanding1.17B
P/E Ratio (TTM)58.60
Price to Sales (P/S)2.38
Price to Book (P/B)5.31
EV/EBITDA20.43
Revenue (TTM)17.31B
Net Income (TTM)703.00M
Free Cash Flow (TTM)1.35B
EPS (TTM)$0.60
Profit Margin4.06%
Operating Margin15.47%
Return on Equity (ROE)9.06%
Debt to Equity2.14
50-Day MA$33.37
200-Day MA$31.18
52-Week Change116.00%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%
Last Dividend Ex-DateNov 27, 2017

Frequently Asked Questions About Teva Pharmaceutical Industries

What is the current stock price for TEVA?

As of the latest trading session, TEVA stock trades at $36.77. The 52-week range is $16.26–$37.35, with a day range of $36.09–$36.81.

What is the P/E ratio for TEVA?

Teva Pharmaceutical Industries's trailing P/E ratio is 58.6, meaning investors pay $58.6 for every $1 of annual earnings. Teva Pharmaceutical Industries operates in the Healthcare sector.

Does TEVA pay dividends?

Teva Pharmaceutical Industries does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for TEVA?

Based on 7 analysts, the consensus for TEVA is Buy.

What is the market cap of TEVA?

Teva Pharmaceutical Industries's market capitalization is $42.84B, classifying it as a large-cap company. Teva Pharmaceutical Industries operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.